Skip to content Skip to footer
Oncology (Solid Tumors)

Tests applicable to Individuals who fall in one or more of the categories mentioned below.

1. Members of families with a history of cancer.
2. Cancer patients who may benefit from pharmacotherapeutic guidance and stratification for prognosis.
3. Early onset breast cancer or triple negative breast cancer.
4. Early onset colon, ovarian, renal, lung cancer, etc.
5. Patients diagnosed with multiple primary cancers.
6. Patients with an identified hereditary cancer syndrome.

Test No.Test NameAnalytical TechniqueSample requiredTAT
ONCNGS168BRAF V600 region sequencingNGSParaffin block/ Fresh tissue4-5 weeks
ONCNGS160KRAS mutation analysis (codons 12, 13, 61 & 146) by NGSNGSParaffin Block/ Fresh tissue4-5 weeks
ONCNGS158EGFR mutation analysis (exons 18, 19, 20 and 21) by NGSNGSParaffin Block/ Fresh tissue4-5 weeks
ONCNGS387EGFR T790M Quantitative mutation detection by NGSNGSParaffin Block/ Fresh tissue4-5 weeks
ONCNGS236EGFR (exons 18, 19, 20 and 21) and KRAS (codons 12, 13, 61 and 146) ultradeep mutation analysis by Next Generation SequencingNGSParaffin Block/ Fresh tissue4-5 weeks
ONCNGS045BRCause NGS Panel – Full sequencing of BRCA1 and BRCA2NGSBlood in EDTA4-5 weeks
ONCNGS046BRCause Extended NGS Panel – Full sequencing of BRCA1, BRCA2, ATM, BRIP1, NBN, RAD51C, RAD51D, PALB2, STK11, CHEK2, PTEN, TP53, CDH1, MLH1, MSH2, MSH6, PMS2, APC, SMAD4, BLM, FANCC, ERCC2 and EPCAM genesNGSBlood in EDTA4-5 weeks
ONCMLP203BRCopy: BRCA1, BRCA2 copy number variations and large gene rearrangementsMLPABlood in EDTA10 days
ONCNGS393Germline panel for FAP (Familial Adenomatous Polyposis) (Next Generation Sequencing of APC, MUTYH genes)NGSBlood in EDTA4-5 weeks
ONCNGS241Germline Panel for Hereditary Non-polyposis Colorectal Carcinoma (HNPCC)/ Lynch Syndrome (Next Generation Sequencing of EPCAM, MLH1, MSH2, MSH6 and PMS2)NGSBlood in EDTA4-5 weeks
ONCNGS244Next Generation Sequencing panel for Multiple Endocrine Neoplasia (MEN) including RET and MEN1 genesNGSBlood in EDTA4-5 weeks
ONCNGS248Retinoblastoma (RB1 gene Next Generation Sequencing)NGSBlood in EDTA4-5 weeks
ONCFRG429Microsatellite Instability (MSI) by Fragment analysisFragment AnalysisFFPE Blocks/ Tissue + Blood in EDTA2 weeks
ONCMLP389MLPA for Von Hippel Lindau (VHL) SyndromeMLPABlood in EDTA10 days
NEPSEQ272Von Hippel Lindau Syndrome (Sequencing of exons 1, 2 and 3 of the VHL gene)CE-SeqBlood in EDTA2-3 weeks
ONCSEQ399Targeted sequencing in VHL, gene (for family members at risk)CE-SeqBlood in EDTA2 weeks
INDHC2440Human Papillomavirus (HPV) testing for Cervical Cancer Risk by HC2Hybrid Capture 2Cervical specimen in SurePath collection vialEvery Thursday
INDNGS441Human Papillomavirus (HPV) genotyping by NGS (RUO)NGSCervical specimen in SurePath collection vial4-5 weeks
674 S. Wagner Road,
Ann Arbor, MI 48103
Tel: +1-734-365-7722
India Office
Manikchand Galleria, 7th Floor, Swastik Society Model Colony, Pune, 411016, Maharashtra, India
Phone: +91 20 7153 1631
Mobile: +91 96073 00010

GenePath Diagnostics © 2023. All Rights Reserved.